V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20024410 | 20010374 | 1.74 | 67.6 | Adjuvant (A) | 2018-03-15 | 2018-03-30 | FEC + DOCETAXEL | 02 | Y | 20086255 | FEC + DOCETAXEL |
| 20024411 | 20010374 | 1.66 | 132 | Adjuvant (A) | 2017-07-03 | 2017-07-29 | FEC + DOCETAXEL | N | null | 20086255 | FEC + DOCETAXEL |
| 20024412 | 20010374 | 1.63 | 67.2 | Adjuvant (A) | 2015-01-21 | 2015-02-02 | FEC 100 + DOCETAXEL | 2 | N | 20086255 | FEC + DOCETAXEL |
| 20024413 | 20010374 | 1.6 | 78 | Not known (9) | 2016-12-04 | 2016-12-14 | FEC 100 + DOCETAXEL | N | N | 20086255 | FEC + DOCETAXEL |
| 20024414 | 20010374 | 1.57 | 88.85 | Curative (C) | 2017-08-11 | 2017-08-11 | FEC + DOCETAXEL | 02 | N | 20086255 | FEC + DOCETAXEL |
| 20024415 | 20010375 | 1.73 | 64.1 | Adjuvant (A) | 2013-04-11 | 2013-04-17 | FEC + DOCETAXEL | 02 | N | 20086262 | FEC + DOCETAXEL |
| 20024416 | 20010375 | 1.65 | 70 | Adjuvant (A) | 2017-01-19 | 2017-02-02 | FEC 100 + DOCETAXEL | 2 | N | 20086262 | FEC + DOCETAXEL |
| 20024417 | 20010375 | null | 69 | Adjuvant (A) | 2017-10-06 | 2017-10-20 | FEC + DOCETAXEL | null | null | 20086262 | FEC + DOCETAXEL |
| 20024418 | 20010376 | 1.61 | 72.4 | Neo-adjuvant (N) | 2013-10-15 | 2013-10-28 | FEC + DOCETAXEL | 02 | N | 20086280 | FEC + DOCETAXEL |
| 20024419 | 20010376 | 1.62 | 60.6 | Adjuvant (A) | 2014-06-12 | 2014-06-15 | FEC + DOCETAXEL | 02 | N | 20086280 | FEC + DOCETAXEL |
| 20024420 | 20010377 | null | 74.4 | Neo-adjuvant (N) | 2015-04-03 | 2015-04-03 | FEC + DOCETAXEL | 02 | Y | 20086286 | FEC + DOCETAXEL |
| 20024421 | 20010377 | 1.68 | 121 | Adjuvant (A) | 2013-11-11 | 2013-12-03 | FEC + DOCETAXEL | N | N | 20086286 | FEC + DOCETAXEL |
| 20024422 | 20010377 | 1.67 | 88 | Adjuvant (A) | 2013-04-21 | 2013-04-29 | FEC + DOCETAXEL | N | N | 20086286 | FEC + DOCETAXEL |
| 20024423 | 20010378 | null | null | Neo-adjuvant (N) | null | 2013-03-02 | FEC 100 + DOCETAXEL | null | null | 20086290 | FEC + DOCETAXEL |
| 20024424 | 20010379 | 1.67 | 78.6 | Neo-adjuvant (N) | 2016-11-06 | 2016-11-20 | FEC + DOCETAXEL | N | null | 20086291 | FEC + DOCETAXEL |
| 20024425 | 20010380 | null | 77.7 | Adjuvant (A) | 2015-02-13 | 2015-02-15 | FEC + DOCETAXEL | 02 | Y | 20086294 | FEC + DOCETAXEL |
| 20024426 | 20010380 | 1.63 | 78.1 | Adjuvant (A) | 2016-04-19 | 2016-04-20 | FEC + DOCETAXEL | 02 | N | 20086294 | FEC + DOCETAXEL |
| 20024427 | 20010380 | 1.56 | 62.5 | Adjuvant (A) | 2015-06-27 | 2015-06-27 | FEC + DOCETAXEL | 2 | N | 20086294 | FEC + DOCETAXEL |
| 20024428 | 20010381 | 1.72 | 56 | Curative (C) | null | 2017-06-06 | FEC + DOCETAXEL | N | N | 20086306 | FEC + DOCETAXEL |
| 20024429 | 20010382 | null | 86.4 | Not known (9) | 2013-12-05 | 2013-12-12 | FEC + DOCETAXEL | 02 | N | 20086320 | FEC + DOCETAXEL |
| 20024430 | 20010383 | 1.59 | 74.4 | Adjuvant (A) | 2014-05-23 | 2014-06-05 | FEC + DOCETAXEL | 2 | N | 20086341 | FEC + DOCETAXEL |
| 20024431 | 20010384 | 1.78 | 64 | Adjuvant (A) | 2017-09-01 | 2017-09-22 | FEC + DOCETAXEL | 02 | N | 20086342 | FEC + DOCETAXEL |
| 20024432 | 20010384 | 1.5 | 83.6 | Not known (9) | null | 2016-09-06 | FEC + DOCETAXEL | N | N | 20086342 | FEC + DOCETAXEL |
| 20024433 | 20108473 | 1.63 | 68.4 | Not known (9) | 2014-09-21 | 2014-10-04 | FEC + DOCETAXEL | 02 | null | 20086352 | FEC + DOCETAXEL |
| 20024434 | 20010385 | null | null | Adjuvant (A) | 2017-07-12 | 2017-08-01 | FEC + DOCETAXEL | 99 | N | 20086353 | FEC + DOCETAXEL |
| 20024435 | 20010386 | 1.62 | 63.8 | Adjuvant (A) | 2015-06-29 | 2015-06-30 | FEC 100 + DOCETAXEL | 2 | N | 20086354 | FEC + DOCETAXEL |
| 20024436 | 20010386 | 1.82 | 83.4 | Adjuvant (A) | 2014-09-16 | 2014-09-16 | FEC 100 + DOCETAXEL | 02 | N | 20086354 | FEC + DOCETAXEL |
| 20024437 | 20010387 | 1.62 | 81.3 | Adjuvant (A) | 2015-08-21 | 2015-08-23 | FEC + DOCETAXEL | 02 | null | 20086357 | FEC + DOCETAXEL |
| 20024438 | 20010387 | 1.57 | null | Neo-adjuvant (N) | 2015-02-19 | 2015-02-24 | FEC + DOCETAXEL | 2 | N | 20086357 | FEC + DOCETAXEL |
| 20024439 | 20010388 | 1.65 | 62.8 | Not known (9) | 2013-06-20 | 2013-06-20 | FEC + DOCETAXEL | 02 | N | 20086359 | FEC + DOCETAXEL |
| 20024440 | 20010388 | 1.75 | 54 | Adjuvant (A) | 2014-06-14 | 2014-06-25 | FEC + DOCETAXEL | 2 | N | 20086359 | FEC + DOCETAXEL |
| 20024441 | 20010389 | null | 76.3 | Neo-adjuvant (N) | 2013-07-24 | 2013-07-27 | FEC + DOCETAXEL | 2 | N | 20086362 | FEC + DOCETAXEL |
| 20024442 | 20010390 | 1.69 | 69.7 | Adjuvant (A) | 2013-09-27 | 2013-10-05 | FEC 100 + DOCETAXEL | 02 | N | 20086367 | FEC + DOCETAXEL |
| 20024443 | 20010390 | null | 64.5 | null | 2018-01-19 | 2018-01-26 | FEC + DOCETAXEL | N | N | 20086367 | FEC + DOCETAXEL |
| 20024444 | 20010391 | 1.6 | 52.6 | Adjuvant (A) | 2016-06-10 | 2016-06-24 | FEC 100 + DOCETAXEL | N | N | 20086370 | FEC + DOCETAXEL |
| 20024445 | 20010391 | null | null | Adjuvant (A) | 2016-12-10 | 2017-01-03 | FEC + DOCETAXEL | null | N | 20086370 | FEC + DOCETAXEL |
| 20024446 | 20010391 | null | 82.55 | Adjuvant (A) | 2015-07-23 | 2015-08-28 | FEC 60 OR 75 + DOCETAXEL | N | N | 20086370 | FEC + DOCETAXEL |
| 20024447 | 20010391 | 1.76 | 126.6 | Not known (9) | 2017-09-16 | 2017-09-26 | FEC 100 + DOCETAXEL | 02 | N | 20086370 | FEC + DOCETAXEL |
| 20024448 | 20010391 | 1.66 | 65 | Adjuvant (A) | 2017-11-16 | 2017-12-12 | FEC + DOCETAXEL | N | N | 20086370 | FEC + DOCETAXEL |
| 20024449 | 20010391 | 1.61 | 67 | Adjuvant (A) | 2016-06-09 | 2016-06-13 | FEC + DOCETAXEL | 02 | null | 20086370 | FEC + DOCETAXEL |
| 20024450 | 20010391 | 1.64 | 51.5 | Adjuvant (A) | 2013-06-23 | 2013-06-24 | FEC + DOCETAXEL | 02 | null | 20086370 | FEC + DOCETAXEL |
| 20024451 | 20010392 | 1.59 | 106 | Adjuvant (A) | 2017-06-21 | 2017-07-01 | FEC + DOCETAXEL | 02 | N | 20086405 | FEC + DOCETAXEL |
| 20024452 | 20010392 | 1.72 | 0 | Adjuvant (A) | 2014-06-25 | 2014-07-15 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20086405 | FEC + DOCETAXEL |
| 20024453 | 20010392 | 1.67 | 108.8 | Adjuvant (A) | 2014-10-06 | 2014-10-06 | FEC + DOCETAXEL | 2 | N | 20086405 | FEC + DOCETAXEL |
| 20024454 | 20010393 | 1.66 | 83.55 | Adjuvant (A) | 2016-09-28 | 2016-10-09 | FEC + DOCETAXEL | 02 | null | 20086410 | FEC + DOCETAXEL |
| 20024455 | 20010393 | 1.66 | 67.8 | Neo-adjuvant (N) | 2016-03-31 | 2016-03-31 | FEC + DOCETAXEL | 02 | N | 20086410 | FEC + DOCETAXEL |
| 20024456 | 20010393 | null | 67 | Neo-adjuvant (N) | 2013-04-27 | 2013-05-26 | FEC + DOCETAXEL | N | null | 20086410 | FEC + DOCETAXEL |
| 20024457 | 20010393 | 1.7 | 99.75 | Adjuvant (A) | 2014-05-10 | 2014-05-17 | FEC + DOCETAXEL | 02 | N | 20086410 | FEC + DOCETAXEL |
| 20024458 | 20010393 | 1.59 | null | Curative (C) | 2013-10-14 | 2013-10-20 | FEC + DOCETAXEL | N | N | 20086410 | FEC + DOCETAXEL |
| 20024459 | 20010394 | 1.67 | 79 | Adjuvant (A) | 2015-04-04 | 2015-04-18 | FEC 100 + DOCETAXEL | N | N | 20086435 | FEC + DOCETAXEL |